Q2 2024 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2024-08-09 · accession 0001172661-24-003184
$102.8M
Reported value
8
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $54.5M | 53.0% | 503,094 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $16.5M | 16.0% | 571,047 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $11.0M | 10.7% | 4,697,785 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $7.9M | 7.70% | 510,000 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $4.5M | 4.35% | 230,000 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $3.7M | 3.58% | 278,393 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $2.4M | 2.36% | 57,343 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $2.4M | 2.30% | 603,937 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.